Connect with us

Hi, what are you looking for?

Entertainment

NHS: Drug-induced ‘chestfeeding’ safe from transgender mothers

via Pixabay
This article was originally published at StateOfUnion.org. Publications approved for syndication have permission to republish this article, such as Microsoft News, Yahoo News, Newsbreak, UltimateNewswire and others. To learn more about syndication opportunities, visit About Us.

An National Health Service (NHS) trust stated that milk produced through pharmaceutical induction of lactation in biological males is as healthy for babies as breastmilk from biological mothers.

The trust cited a study claiming milk from transgender women taking hormones like domperidone had low testosterone levels and caused no side effects in babies over 5 months.

Longer term effects were not studied.

While advising staff to warn parents about medication transfer risks, the trust deemed drug-induced “chestfeeding” safe.

NHS reportedly recommended telling “any parent who is taking medication (for whatever reason) to seek advice on the possibility of that medication being transferred to the baby through breastfeeding and also the health implications for the baby.”

Critics argue prioritizing transgender identities over infant health is disturbing, and that hormone treatment cannot truly replicate the nutritional benefits of natural breastmilk.

Molitum wrote in a statement, “Small amounts have been detected in breastmilk. Motilium may cause unwanted side effects affecting the heart in a breastfed baby. [It] should be used during breastfeeding only if your physician considers this clearly necessary.”

The Director of Sex Matters, Maya Forstater, said, “For a chief executive and medical director of an NHS trust to prioritize trans identities over what is best for mothers and their babies is deeply disturbing.”

Lottie Moore, of the Policy Exchange think tank,described the NHS as an “unbalanced and naïve in its assertion that the secretions produced by a male on hormones can nourish an infant in the way a mother’s breast milk can.”

The trust maintains it stands by the letter’s facts and cited evidence, despite the drug manufacturer warning against its use in breastfeeding due to potential heart risks for babies.

The University of Sussex Hospitals NHS Trust (USHT) wrote, “We stand by the facts of the letter and the cited evidence supporting them.”

Most Popular:

Cause of Death Released For ‘Rocky’ Movie Star

Supreme Court Audio Suggests Trump Case Is Doomed

You May Also Like

Trending